Kegg medicus dgroup
| DG02854 | |
| DG番号 | DG02854 |
| 分類 | DGroup |
| 名称 | SLC22A2 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | DG00018 Ranitidine D00422 Ranitidine (USAN/INN) D00673 Ranitidine hydrochloride (JP18/USP) D05699 Ranitidine bismuth citrate (USAN) D00318 Famotidine (JP18/USP/INN) DG00193 Procainamide D08421 Procainamide (INN) D00477 Procainamide hydrochloride (JP18/USP) DG00213 Dopamine D07870 Dopamine (INN) D00633 Dopamine hydrochloride (JP18/USP) D00513 Pindolol (JP18/USP/INN) D11521 Lamivudine, nevirapine and zidovudine D00275 Cisplatin (JP18/USP/INN) D01790 Oxaliplatin (JAN/USP/INN) DG00860 Amantadine D07441 Amantadine (INN) D00777 Amantadine hydrochloride (JP18/USP) DG00986 Memantine D08174 Memantine (INN) D04905 Memantine hydrochloride (JAN/USP) DG01107 Cetirizine D07662 Cetirizine (INN) D00664 Cetirizine hydrochloride (JP18/USP) |
| 上位グループ | Transporter substrate |
| 注釈1 | - |
| 注釈2 | - |